StockWatch
·
HomeLiveWeekly
Pharmaceuticals
Board Meeting30 Apr 2026, 11:45 am

Abbott India Board Meeting on May 11, 2026 for Results & Dividend

AI Summary

Abbott India Ltd has scheduled a Board of Directors meeting on May 11, 2026, to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026. The board will also consider approving the audited financial statements for the same period and recommend a final dividend. The trading window remains closed from April 1, 2026, to May 13, 2026.

Key Highlights

  • Board meeting scheduled for May 11, 2026 to approve financial results.
  • Audited financial results for FY26 will be considered.
  • Final dividend for the year ended March 31, 2026 to be recommended.
  • Trading window closed from April 1 to May 13, 2026.
View BSE Filing
ABBOTINDIA
Pharmaceuticals
ABBOTT INDIA LTD.

Price Impact

More from ABBOTINDIA

Insider Trading26 Jun, 2:55 pm

Abbott India Closes Trading Window for Insider Trading Compliance

Dividend15 Jun, 2:45 pm

Abbott India: TDS on Dividend Intimation to Shareholders

Management Change25 May, 5:31 pm

Abbott India Appoints Swati Pathak as Associate Director

More in Board Meeting

SAMBHV1d ago, 8:00 pm

Sambhv Steel Tubes Board Meeting on July 15, 2026 to Consider Fund Raising

VINEETLAB1d ago, 7:40 pm

Vineet Laboratories Board Meeting on July 15, 2026 for Audited Results

LTIM1d ago, 7:10 pm

LTM (ex-LTIMindtree) Q1 strong: consol PAT +17% YoY to ₹1,469 Cr, revenue +18%, margins expand